journal article·2022-10Open access

Rational Amphiphilic Ligand Engineering Enables Enhanced Stability and Efficiency of CsPbBr3 Nanocrystals Based Light Emitting Diodes

Yanyan Duan, Kalyani Chordiya, Mousumi Upadhyay Kahaly, Freddy E. Oropeza, Víctor A. de la Peña O'Shea, De‐Yi Wang, Rubén D. Costa

Advanced Optical Materials· Volume 10· Issue 20

Abstract

Abstract Metal halide perovskites have shown great potential for lighting. However, their low stability under irradiation/thermal stress and/or ambient storage conditions are critical for light‐emitting diodes (LEDs). Among the stabilization strategies, ligand surface modification is effective toward stable perovskites, but the dynamic ligand adsorption/desorption process on the surface is a limiting factor. Herein, a new family of biogenic and amphiphilic capping agents, phosphatidyl‐L‐serine (Ptd‐L‐Ser), combining stronger multibinding motifs compared to conventional capping agents has led to superior CsPbBr3 (CsPbBr3‐Ptd‐L‐Ser) with significantly enhanced stability upon storage/heating/water, keeping excellent photoluminescence quantum yields of ≈80% over half year. Spectroscopic/theoretical studies reveal that the origin of this behavior is the increased exciton binding energy associated to the versatility of multiple bindings. This results in CsPbBr3‐Ptd‐L‐Ser nanocrystals‐based green‐LEDs featuring excellent stabilities of >700 h (20 mA) and >200 h (100 mA) that strongly contrast with the reference devices with pristine CsPbBr3 nanocrystals (120 h (20 mA) and 27 h (100 mA)). White LEDs (WLEDs) with chromaticity coordinates of (0.34, 0.33) and high luminous efficiency of 76 lm W–1, keeping stable over weeks, are further demonstrated under continuous operational conditions, thereby suggesting CsPbBr3‐Ptd‐L‐Ser nanocrystals can be a potential candidate for commercial WLED technology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Perovskite Materials and Applications · 2D Materials and Applications · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

IMDEA Materials Institute Calle Eric Kandel 2 Getafe 28906 Spain

ELI ALPS ELI‐HU Non‐Profit Ltd Wolfgang Sandner utca 3 Szeged H‐6728 Hungary

Institute of Physics University of Szeged Dóm tér 9 Szeged H‐6720 Hungary

Photoactivated Processes Unit IMDEA Energy Institute Avda. Ramón de la Sagra, 3 Mostoles Madrid 28935 Spain

Chair of Biogenic Functional Materials Technical University of Munich Schulgasse 22 D‐94315 Straubing Germany

Funding

European Regional Development Fund · Comunidad de Madrid

References (46)

Show source-provided references
1. 10.1038/s41566-021-00766-210.1038/s41566-021-00766-2 ↗
2. 10.1038/s41586-021-03217-810.1038/s41586-021-03217-8 ↗
3. 10.1038/s41566-021-00863-210.1038/s41566-021-00863-2 ↗
4. 10.1038/s41566-021-00855-210.1038/s41566-021-00855-2 ↗
5. 10.1038/s41566-021-00857-010.1038/s41566-021-00857-0 ↗
6. 10.1021/nl504877910.1021/nl5048779 ↗
7. 10.1002/adma.20210368810.1002/adma.202103688 ↗
8. 10.1002/adfm.20200540110.1002/adfm.202005401 ↗
9. 10.1038/s41563-018-0018-410.1038/s41563-018-0018-4 ↗
10. 10.1002/adfm.20210463410.1002/adfm.202104634 ↗
11. 10.1039/C8CS00740C10.1039/C8CS00740C ↗
12. 10.1002/adfm.20160010910.1002/adfm.201600109 ↗
13. 10.1002/adma.20170458710.1002/adma.201704587 ↗
14. 10.1002/adma.20190068210.1002/adma.201900682 ↗
15. 10.1021/acsami.1c0402510.1021/acsami.1c04025 ↗
16. 10.1002/adma.20160308110.1002/adma.201603081 ↗
17. 10.1021/acsnano.5b0629510.1021/acsnano.5b06295 ↗
18. 10.1021/acs.chemrev.8b0064410.1021/acs.chemrev.8b00644 ↗
19. 10.1021/acsenergylett.8b0003510.1021/acsenergylett.8b00035 ↗
20. 10.1002/adfm.20210043810.1002/adfm.202100438 ↗
21. 10.1126/science.abf446010.1126/science.abf4460 ↗
22. 10.1002/anie.20190453710.1002/anie.201904537 ↗
23. 10.1002/anie.20200695610.1002/anie.202006956 ↗
24. 10.1002/adma.20200588810.1002/adma.202005888 ↗
25. 10.1021/jacs.7b1064710.1021/jacs.7b10647 ↗
26. 10.1002/adma.20200882010.1002/adma.202008820 ↗
27. 10.1021/jacs.9b0996910.1021/jacs.9b09969 ↗
28. 10.1002/anie.20201498310.1002/anie.202014983 ↗
29. 10.1002/adma.20190160210.1002/adma.201901602 ↗
30. 10.1021/ja00072a02510.1021/ja00072a025 ↗
31. 10.1002/anie.20201044010.1002/anie.202010440 ↗
32. 10.1021/jacs.0c0368210.1021/jacs.0c03682 ↗
33. 10.1002/anie.20191649210.1002/anie.201916492 ↗
34. 10.1021/jacs.7b0281710.1021/jacs.7b02817 ↗
35. 10.1016/j.apcatb.2009.06.03510.1016/j.apcatb.2009.06.035 ↗
36. 10.1016/j.ijpharm.2006.12.02110.1016/j.ijpharm.2006.12.021 ↗
37. 10.1021/cs501124d10.1021/cs501124d ↗
38. 10.1002/adma.20200716910.1002/adma.202007169 ↗
39. 10.1002/adma.20200198910.1002/adma.202001989 ↗
40. 10.1021/acsnano.8b0518510.1021/acsnano.8b05185 ↗
41. 10.1016/j.matt.2021.09.00710.1016/j.matt.2021.09.007 ↗
42. 10.1002/adma.20170620810.1002/adma.201706208 ↗
43. 10.1021/acsnano.8b0517210.1021/acsnano.8b05172 ↗
44. 10.1002/adma.20200525510.1002/adma.202005255 ↗
45. 10.1002/jcc.105610.1002/jcc.1056 ↗
46. 10.1021/acs.chemmater.9b0068010.1021/acs.chemmater.9b00680 ↗